Internal Medicine, Hematology & Oncology · Fairfield, CT
NPI
1093924417
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
425 Post Rd
Fairfield, CT, 06824
Phone (203) 255-4545
Groups this clinician bills Medicare through
Medicare paid, 2024
$70K
874 services
Medicare patients, 2024
276
Average age 75
Drug cost, 2024
$2.8M
1,385 prescriptions
Company payments, 2025
$799
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sandhya Dhanjal was code 99214 (office e&m - established), 491 times for 186 patients. In total Sandhya Dhanjal billed 874 services in 13 codes, and Medicare paid $70K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-02-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 491 | 186 | $83.15 | $41K |
| 99232 Hospital E&M - Subsequent | Facility | 146 | 45 | $65.93 | $9,626 |
| 99213 Office E&M - Established | Office | 136 | 72 | $54.44 | $7,404 |
| 99222 Hospital E&M - Initial | Facility | 45 | 40 | $112.57 | $5,066 |
| 99205 Office E&M - New | Office | 26 | 26 | $155.41 | $4,041 |
By year: 2022 $84K for 1,074 services; 2023 $79K for 939 services; 2024 $70K for 874 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sandhya Dhanjal prescribed most often to Medicare patients was Anastrozole, with 374 prescriptions and refills. In total Sandhya Dhanjal wrote 1,385 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 374 | 797 | 89 | $5,926 |
| Alendronate Sodium Generic | 132 | 262 | 36 | $888 |
| Eliquis Apixaban | 100 | 121 | 20 | $71K |
| Hydroxyurea Generic | 64 | 122 | 13 | $988 |
| Exemestane Generic | 61 | 125 | 13 | $11K |
| Dexamethasone Generic | 57 | 57 | 20 | $724 |
| Revlimid Lenalidomide | 41 | 41 | Under 11 | $739K |
| Ondansetron Hcl Generic | 40 | 40 | 11 | $374 |
| Pantoprazole Sodium Generic | 31 | 57 | 12 | $112 |
| Imatinib Mesylate Generic | 31 | 31 | Under 11 | $214K |
| Acyclovir Generic | 28 | 56 | Under 11 | $643 |
| Letrozole Generic | 24 | 44 | Under 11 | $393 |
| Xarelto Rivaroxaban | 23 | 33 | Under 11 | $19K |
| Erleada Apalutamide | 22 | 22 | Under 11 | $295K |
| Loperamide Loperamide Hcl | 19 | 19 | 14 | $139 |
Brand drugs: - claims; generic drugs: 1,072 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sandhya Dhanjal $799 ($799 in general payments such as food, travel and fees) from 19 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $106.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 4 | $106 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $87.2 |
| Jazz Pharmaceuticals Inc. JAZZ | 4 | $82.03 |
| Array Biopharma Inc PFE | 3 | $72.2 |
| Abbvie Inc. ABBV | 3 | $62.05 |
| GlaxoSmithKline, LLC. GSK | 2 | $50.03 |
| Genentech USA, Inc. ROG.SW | 2 | $47.58 |
| Janssen Biotech, Inc. JNJ | 1 | $43.13 |
| Lilly USA, LLC LLY | 1 | $30 |
| Pharmacosmos Therapeutics Inc. | 1 | $26.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.